AD is a devastating neurodegenerative disorder characterized by progressive loss of memory and cognitive functions. The long-term goal of this research is to elucidate the role of B-amyloid protein (AB) and apolipoprotein E (apoE) in the pathogenesis of AD. A possible role for AB as either a marker for AD onset and progression or as a causative factor is supported by its marked accumulation in neuritic plaques and cerebrovascular sites. Genetic, epidemiological, and biochemical evidence is mounting that apoE exerts an isoform specific-effect on the rate or extent of development of AD. We have already demonstrated that over-expression of a C-terminal region of amyloid precursor protein (BPP) leads to the production of AB-bearing 14 and 15 kDa neurotoxic fragments in cultured neuronal cells. In addition, we have already created transgenic mice that overproduce these 14 and 15 kDa fragments. These mice produce more protein product in brain than reported by any other investigator. Although we have not observed any obvious pathological changes in the brains of our transgenic mice (up to 26 months), amyloid deposits have been observed in the intestines of these mice. We hypothesize that other factors may be necessary for the induction of neuropathological changes associated with AD, such as expression of specific apoE alleles, or quantities of these alleles. Thus, the specific aims of this research proposal are to: (1) establish transgenic mice over-expressing human apoE3 and apoE4; (2) establish transgenic mice over-expressing human AB with different apoE genotypes; and (3) analyze transgenic mouse lines for AD symptoms. ApoE allele specific cDNA constructs will be made with a cytomegalovirus promoter system. Over-expression of human apoE (apoE3-E3 mice and apoE4-E4 mice) will be established in mice lacking endogenous apoE expression (apoE """"""""knock-out"""""""" mice) by a combination of transgenic and breeding schemes. These mice will be studied and crossed to mice over-expressing AB to determine the effects of each genetic change and gene interactions on the propensity of AD pathology. The development of animal models expressing various forms of apoE in the presence of marked amyloid expression may provide excellent tools in which to study the progression, prevention, and treatment of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005136-15S1
Application #
6295365
Study Section
Project Start
1998-08-15
Project End
1999-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Goins, R Turner; Schure, Mark; Jensen, Paul N et al. (2018) Lower body functioning and correlates among older American Indians: The Cerebrovascular Disease and Its Consequences in American Indians Study. BMC Geriatr 18:6
Iverson, Grant L; Keene, C Dirk; Perry, George et al. (2018) The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. J Alzheimers Dis 61:17-28
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Flanagan, Margaret E; Keene, Christopher Dirk; Louis, David N et al. (2018) Localized crystal-storing histiocytosis of the posterior fossa. Neuropathology 38:529-534
Rane, Swati; Koh, Natalie; Boord, Peter et al. (2018) Quantitative cerebrovascular pathology in a community-based cohort of older adults. Neurobiol Aging 65:77-85
Dams-O'Connor, Kristen; Sy, Karla Therese L; Landau, Alexandra et al. (2018) The Feasibility of Telephone-Administered Cognitive Testing in Individuals 1 and 2 Years after Inpatient Rehabilitation for Traumatic Brain Injury. J Neurotrauma 35:1138-1145
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71

Showing the most recent 10 out of 753 publications